Natus Medical Inc (BABY) 38.96 $BABY Abiomed (ABMD)

New Post Public Reply Private Reply Replies (0) Message Board

Aug 2, 2016 at 11:57 AM

Natus Medical Inc (BABY) 38.96 $BABY

Abiomed (ABMD) Beats Q1 Earnings & Revenues, Shares Up
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 7:35AM CDT
Abiomed reported earnings of 29 cents per share, which beat the Zacks Consensus Estimate by 7 cents.
BABY: 38.96 (-0.22), ABMD: 117.89 (-1.61), MASI: 52.68 (-0.25), CPHD: 36.25 (-0.51)

Align Technology (ALGN) Q2 Earnings Top, Shipments Rise
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 2:51PM CDT
Align Technology (ALGN) ended second quarter on a promising note, squarely beating the Zacks Consensus Estimate
BABY: 38.96 (-0.22), MASI: 52.68 (-0.25), ALGN: 89.87 (+0.18), CPHD: 36.25 (-0.51)

Qiagen (QGEN) Tops Q2 Earnings & Sales; Margins Drop Y/Y
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 9:08AM CDT
Qiagen (QGEN) ended the second-quarter 2016 on a promising note, squarely beating the Zacks Consensus Estimates.
BABY: 38.96 (-0.22), MASI: 52.68 (-0.25), CPHD: 36.25 (-0.51), QGEN: 26.67 (-0.13)

Cepheid's (CPHD) Q2 Loss Narrower than Estimate, View Up
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 2:09PM CDT
Cepheid (CPHD) posted second-quarter 2016 adjusted loss per share of 9 cents.
BABY: 38.96 (-0.22), ABMD: 117.89 (-1.61), MASI: 52.68 (-0.25), CPHD: 36.25 (-0.51)

GNC Holdings (GNC) Tops Q2 Earnings, Suspends '16 View
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 2:01PM CDT
GNC Holdings (GNC) ended second-quarter 2016 on a disappointing note as its revenue figure failed to meet the Zacks Consensus Estimate.
BABY: 38.96 (-0.22), ABMD: 117.89 (-1.61), MASI: 52.68 (-0.25), GNC: 19.79 (-0.18)

HCA Holdings (HCA) Beats Q2 Earnings, Raises FY16 View
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 10:12AM CDT
HCA Holdings Inc. (HCA) reported second-quarter 2016 adjusted earnings of $1.66 per share, which beat the Zacks Consensus Estimate by 11 cents.
HCA: 75.06 (-0.46), BABY: 38.96 (-0.22), ABMD: 117.89 (-1.61), WCG: 109.18 (+2.30)

ResMed (RMD) Q4 Earnings in Line, Revenues Top Estimates
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 9:14AM CDT
ResMed ended fiscal 2016 on a modest note, with fourth-quarter revenues beating estimates and earnings meeting the same.
BABY: 38.96 (-0.22), ABMD: 117.89 (-1.61), MASI: 52.68 (-0.25), RMD: 69.65 (-0.20)

Thermo Fisher (TMO) Tops Q2 Earnings, Sales; Updates View
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 2:31PM CDT
Thermo Fisher's (TMO) financial numbers squarely beat the Zacks Consensus Estimate in the second quarter
BABY: 38.96 (-0.22), ABMD: 117.89 (-1.61), MASI: 52.68 (-0.25), TMO: 156.49 (-3.07)

Mead Johnson (MJN) Tops Q2 Earnings, Sales Down Y/Y (Revised)
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 10:43AM CDT
Mead Johnson's (MJN) second-quarter results were a mixed bag, with the bottom line comfortably beating the Zacks Consensus Estimate and revenues missing the same.
BABY: 38.96 (-0.22), ABMD: 117.89 (-1.61), MJN: 86.31 (-1.41), MASI: 52.68 (-0.25)

Varian Medical (VAR) Beats Q3 Earnings & Sales; View Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 10:15AM CDT
Varian Medical Systems Inc. (VAR) reported earnings of $1.22 per share in the third quarter of fiscal 2016, which beat the Zacks Consensus Estimate by a nickel.
BABY: 38.96 (-0.22), ABMD: 117.89 (-1.61), MASI: 52.68 (-0.25), VAR: 94.39 (-0.45)

Hologic (HOLX) Beats on Q3 Earnings, Sales; '16 View Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 5:29AM CDT
Hologic (HOLX) ended third-quarter fiscal 2016 on a promising note, with both its top and bottom line comfortably exceeding the Zacks Consensus Estimate.
BABY: 38.96 (-0.22), ABMD: 117.89 (-1.61), MASI: 52.68 (-0.25), HOLX: 39.09 (+0.11)

MedTech Tailwinds at a Glance: Which Stocks to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 5:02PM CDT
MedTech Tailwinds at a Glance: Which Stocks to Buy?
ABMD: 117.89 (-1.61), LDRH: 36.98 (-0.02), MDT: 87.41 (-0.65), PAHC: 20.90 (+0.07), MLAB: 111.68 (-2.42), NUVA: 62.56 (-0.73), BSX: 24.13 (-0.30), BABY: 38.96 (-0.22), SNN: 33.41 (+0.23), JNJ: 124.57 (-0.83), DXCM: 91.99 (-0.66), GWPH: 93.60 (-2.51), RMD: 69.65 (-0.20), WOOF: 69.31 (-1.09), ABT: 45.06 (-0.23), VIVO: 19.34 (-0.21), MASI: 52.68 (-0.25), TMO: 156.49 (-3.07), CYH: 12.10 (-0.48), HTWR: 57.90 (-0.06), FEIC: 106.56 (+0.11), ISRG: 687.25 (-6.62), CFMS: 6.87 (-0.05), STE: 70.93 (-0.48), STJ: 83.41 (-0.32), XRAY: 64.54 (+0.31), HOLX: 39.09 (+0.11)

Can The Uptrend Continue for Natus Medical (BABY)?
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 5:51AM CDT
Investors certainly have to be happy with Natus Medical Inc (BABY) and its short term performance
BABY: 38.96 (-0.22)

Natus Medical Expands Share Repurchase Program by $20M
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:54AM CDT
Natus Medical Inc. (BABY) recently announced an expansion of its share repurchase program, which authorizes it to buy back additional shares worth $20 million by Jun 1, 2017.
BABY: 38.96 (-0.22), MASI: 52.68 (-0.25), EXAC: 26.87 (-0.33), CRY: 14.12 (-0.20)

Natus Announces $20 Million Share Repurchase Program
GlobeNewswire - Fri Jun 03, 6:00AM CDT
Natus Medical Incorporated (NASDAQ:BABY) announced that its Board of Directors has approved an expansion of its existing stock repurchase program, authorizing the repurchase of up to an additional $20 million of the Company's common stock. The expiration date is set for June 1, 2017.
BABY: 38.96 (-0.22)

Natus to Present at Jefferies 2016 Healthcare Conference
GlobeNewswire - Wed Jun 01, 6:00AM CDT
Natus Medical Incorporated (NASDAQ:BABY) today announced that Jim Hawkins, President and Chief Executive Officer, will present at the Jefferies 2016 Healthcare Conference in New York City. Mr. Hawkins is scheduled to present at 3:30 p.m. EDT on Thursday, June 9, 2016.
BABY: 38.96 (-0.22)

Lifshitz & Miller Law Firm Announces Investigation of Amaya, Inc., Chiasma, Inc., Intrexon Corporation, Natus Medical Inc., NRG Yield, Inc., Sunrun Inc., TransEnterix and Vivint Solar, Inc.
PR Newswire - Mon May 09, 7:47PM CDT
Amaya, Inc. (AYA)
BABY: 38.96 (-0.22), RUN: 5.10 (+0.03), XON: 26.26 (-1.12), AYA: 15.17 (-0.19), VSLR: 2.94 (unch), TRXC: 1.74 (+0.44), NYLD: 17.48 (-0.08), CHMA: 2.70 (unch)

Natus to Present at UBS Global Healthcare Conference
GlobeNewswire - Mon May 09, 6:00AM CDT
Natus Medical Incorporated (NASDAQ:BABY) today announced that Jonathan Kennedy, Sr. Vice-President and Chief Financial Officer, will present at the UBS Global Healthcare Conference in New York, NY. Mr. Kennedy is scheduled to present on Tuesday, May 24 at 10:00 a.m. Eastern Time (7:00 a.m. PT).
BABY: 38.96 (-0.22)

ATTENTION NATUS SHAREHOLDERS: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Natus Medical Incorporated; Encourages Investors to Contact the Firm for Additional Information
PR Newswire - Fri Apr 22, 8:30PM CDT
Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by Natus Medical Incorporated (NASDAQ: BABY) and certain of its officers. Natus designs, manufactures and markets newborn care and neurology healthcare products and services worldwide.
BABY: 38.96 (-0.22)

Hagens Berman Investigates Natus Medical Inc.'s Guidance on Prepayments From the Venezuelan Government and the Timing of Insider Sales
BusinessWire - Fri Apr 22, 7:30AM CDT
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, is investigating whether Natus Medical Incorporated. (NASDAQ: BABY) issued false and misleading statements about its expected receipt of prepayments under a contract with the Venezuelan Government and the timing of certain insiders' stock sales, potentially in violation of the securities laws.
BABY: 38.96 (-0.22)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AMD CEO, Global Leaders Converge At IMPERIA Summit

A Clash of Giants in New York The trade floors are buzzing in New York as the world's economic heavyweights and tech titans gather for the inaugural IMPERIA Summit. You can almost smell the pressure and ambition wafting through the streets when folks like AMD's CEO, Lisa Su, share the stage with geopolitical power players like President Trump and China's President Xi...

Amy Wilson Joins ITSA Board: A New Era for UBI?

An Unexpected Turn in the UBI Movement In a world where tech and economic security must dance together, minding the steps is crucial. And this time, Amy Wilson's got her dancing shoes on. On September 24, 2026, the Income To Support All (ITSA) Foundation made some waves by adding Wilson to its board of directors, a move showing they're more serious than ever about...

NSF Backs New Space Projects: Cooling & Drug Delivery

You know, every time we think we're at the edge of current science, space reminds us how little we actually know. From the International Space Station up there in low Earth orbit, fresh experiments are kicking off to change what we understand about electronics cooling and drug delivery. It's a classic scenario of reaching for the stars to help us out back here on Earth....

PostalAnnex Lands at Stanford with New Service Hub

PostalAnnex Makes a Strategic Stanford Move It's not every day you see a company nestling into a place like Stanford University. Annex Brands has just opened its latest PostalAnnex location, a stone’s throw from the academic hustle and bustle of the Stanford campus. The geeky vibe of students and professors rushing with deadlines matches well with the efficient service...

Lincoln Educational Services Faces Securities Fraud Suit

A Storm Brews Over Lincoln Educational Services You know, there's nothing quite like the stink of a good mess in the markets, and Lincoln Educational Services Corporation has found itself knee-deep in one. The buzz is all about some securities fraud allegations that could rope in a bunch of investors who got the short end of the stick. It’s lawsuits like these that make...

Aviator Nation Teams with NFL for 2026 Collection Launch

In a move blending sports with a dash of retro flair, Aviator Nation's dropping its first NFL-licensed collection. They’re looking to serve up a blend of vintage vibes and team spirit. Aviator Nation's New Venture Launching their collection on September 24th, 2026, Aviator Nation takes a dive deeper into sports licensing, after scoring a touchdown (literally!) with an...

illycaffè's B Corp™ Recertification Reflects Bold Commitment

illycaffè Hits Milestone with B Corp™ Recertification In an era where corporate responsibility isn't just fodder for feel-good presentations, illycaffè has proven it’s not just paying lip service to the idea. The Italian coffee titan has secured its B Corp™ recertification under snazzier, sharper V2 standards. This isn't just a shiny sticker to slap on marketing...

Subaru, Motorq Offer Hardware-Free Fleet Telematics Insights

An Unplugged Move in Fleet Management There's something brewing between Motorq and Subaru that could shake up fleet operations in ways most haven't thought possible yet. We’re talking about cutting those pesky hardware cords and diving straight into a future that's software-driven—and hey, we're all here for it. Direct, Data-Driven Leadership Imagine you're a fleet...

VERTESS Tops Axial's 2026 Healthcare M&A Advisor List

Strength Takes Top Spot in Healthcare M&A VERTESS has grabbed the gold medal in healthcare sell-side M&A, something that didn't just fall from the sky. Axial gave them the nod as the cream of the crop among the Top 50 Lower Middle Market Healthcare M&A Advisors for 2026. Evaluating the Strengths that Set VERTESS Apart When Axial, that private deal network that's all about...

Stravito's MCP Server Revolutionizes AI in Business

We're seeing another big swing in how enterprises weave AI into the fabric of decision-making. Stravito, an enterprise customer intelligence platform, launched its Model Context Protocol (MCP) Server. This thing brings company-owned research right into the gizmos teams already use. Now, businesses aren't left groping in the dark figuring out their next moves—pretty...